A detailed history of Cercano Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cercano Management LLC holds 149,387 shares of LLY stock, worth $153 Million. This represents 5.0% of its overall portfolio holdings.

Number of Shares
149,387
Previous 173,783 14.04%
Holding current value
$153 Million
Previous $135 Million 15.86%
% of portfolio
5.0%
Previous 4.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

SELL
$625.65 - $812.69 $15.3 Million - $19.8 Million
-24,396 Reduced 14.04%
149,387 $114 Million
Q2 2025

Aug 08, 2025

BUY
$713.71 - $898.95 $123 Million - $155 Million
172,678 Added 15626.97%
173,783 $135 Million
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $853,214 - $1.06 Million
1,105 New
1,105 $978,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cercano Management LLC Portfolio

Follow Cercano Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cercano Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cercano Management LLC with notifications on news.